NO996438L - New combination of anti-asthma drugs - Google Patents
New combination of anti-asthma drugsInfo
- Publication number
- NO996438L NO996438L NO996438A NO996438A NO996438L NO 996438 L NO996438 L NO 996438L NO 996438 A NO996438 A NO 996438A NO 996438 A NO996438 A NO 996438A NO 996438 L NO996438 L NO 996438L
- Authority
- NO
- Norway
- Prior art keywords
- new combination
- asthma drugs
- kit
- active ingredient
- asthma
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
- A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
Abstract
Preparat eller kit som har som en første aktiv bestanddel formoterol, eller et salt eller solvatderivat derav, og som har som en annen aktiv bestanddel rofleponid, eller en fett- syreester derav. Det er også beskrevet fremgangsmåter for behandling av respiratoriske forstyrrelser ved anvendelse av nevnte preparat eller kit.A composition or kit having as a first active ingredient formoterol, or a salt or solvate derivative thereof, and having as a second active ingredient rofleponide, or a fatty acid ester thereof. Methods are also described for treating respiratory disorders using said preparation or kit.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US88382397A | 1997-06-27 | 1997-06-27 | |
PCT/SE1998/001089 WO1999000134A1 (en) | 1997-06-27 | 1998-06-08 | New combination of antiasthma medicaments |
Publications (2)
Publication Number | Publication Date |
---|---|
NO996438D0 NO996438D0 (en) | 1999-12-23 |
NO996438L true NO996438L (en) | 2000-02-28 |
Family
ID=25383399
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO996438A NO996438L (en) | 1997-06-27 | 1999-12-23 | New combination of anti-asthma drugs |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1009408A1 (en) |
JP (1) | JP2002510310A (en) |
KR (1) | KR20010014162A (en) |
AU (1) | AU8135098A (en) |
BR (1) | BR9810452A (en) |
CA (1) | CA2295076A1 (en) |
EE (1) | EE9900594A (en) |
HU (1) | HUP0002533A3 (en) |
ID (1) | ID24063A (en) |
IL (1) | IL133597A0 (en) |
IS (1) | IS5303A (en) |
NO (1) | NO996438L (en) |
PL (1) | PL337722A1 (en) |
SK (1) | SK184799A3 (en) |
TR (1) | TR199903272T2 (en) |
WO (1) | WO1999000134A1 (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9703407D0 (en) | 1997-09-19 | 1997-09-19 | Astra Ab | New use |
SE9802073D0 (en) | 1998-06-11 | 1998-06-11 | Astra Ab | New use |
GB9912639D0 (en) | 1999-05-28 | 1999-07-28 | Britannia Pharmaceuticals Ltd | Improvements in and relating to treatment of respiratory conditions |
SE9900833D0 (en) * | 1999-03-09 | 1999-03-09 | Astra Ab | Novel combination |
GB0009607D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Medical compositions |
GB0009617D0 (en) * | 2000-04-18 | 2000-06-07 | Glaxo Group Ltd | Respiratory combinations |
US6667344B2 (en) | 2001-04-17 | 2003-12-23 | Dey, L.P. | Bronchodilating compositions and methods |
US20030055026A1 (en) | 2001-04-17 | 2003-03-20 | Dey L.P. | Formoterol/steroid bronchodilating compositions and methods of use thereof |
WO2004028545A1 (en) * | 2002-09-25 | 2004-04-08 | Astrazeneca Ab | A COMBINATION OF A LONG-ACTING β2-AGONIST AND A GLUCOCORTICOSTEROID IN THE TREATMENT OF FIBROTIC DISEASES |
TWI359675B (en) | 2003-07-10 | 2012-03-11 | Dey L P | Bronchodilating β-agonist compositions |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
SE9302777D0 (en) * | 1993-08-27 | 1993-08-27 | Astra Ab | Process for conditioning substances |
HU0004452D0 (en) * | 1991-12-18 | 2001-01-29 | Astra Ab | |
SA95160463B1 (en) * | 1994-12-22 | 2005-10-04 | استرا أكتيبولاج | powders for inhalation |
SE9501384D0 (en) * | 1995-04-13 | 1995-04-13 | Astra Ab | Process for the preparation of respirable particles |
SE9603669D0 (en) * | 1996-10-08 | 1996-10-08 | Astra Ab | New combination |
-
1998
- 1998-06-08 JP JP50547999A patent/JP2002510310A/en active Pending
- 1998-06-08 IL IL13359798A patent/IL133597A0/en unknown
- 1998-06-08 BR BR9810452-7A patent/BR9810452A/en not_active IP Right Cessation
- 1998-06-08 EP EP98931163A patent/EP1009408A1/en not_active Withdrawn
- 1998-06-08 TR TR1999/03272T patent/TR199903272T2/en unknown
- 1998-06-08 SK SK1847-99A patent/SK184799A3/en unknown
- 1998-06-08 ID IDW991684A patent/ID24063A/en unknown
- 1998-06-08 HU HU0002533A patent/HUP0002533A3/en unknown
- 1998-06-08 CA CA002295076A patent/CA2295076A1/en not_active Abandoned
- 1998-06-08 WO PCT/SE1998/001089 patent/WO1999000134A1/en not_active Application Discontinuation
- 1998-06-08 AU AU81350/98A patent/AU8135098A/en not_active Abandoned
- 1998-06-08 PL PL98337722A patent/PL337722A1/en unknown
- 1998-06-08 KR KR1019997012233A patent/KR20010014162A/en not_active Application Discontinuation
- 1998-06-08 EE EEP199900594A patent/EE9900594A/en unknown
-
1999
- 1999-12-15 IS IS5303A patent/IS5303A/en unknown
- 1999-12-23 NO NO996438A patent/NO996438L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
WO1999000134A1 (en) | 1999-01-07 |
CA2295076A1 (en) | 1999-01-07 |
HUP0002533A3 (en) | 2001-03-28 |
IS5303A (en) | 1999-12-15 |
BR9810452A (en) | 2000-09-05 |
KR20010014162A (en) | 2001-02-26 |
NO996438D0 (en) | 1999-12-23 |
EP1009408A1 (en) | 2000-06-21 |
ID24063A (en) | 2000-07-06 |
HUP0002533A2 (en) | 2000-12-28 |
SK184799A3 (en) | 2000-06-12 |
JP2002510310A (en) | 2002-04-02 |
EE9900594A (en) | 2000-08-15 |
IL133597A0 (en) | 2001-04-30 |
PL337722A1 (en) | 2000-08-28 |
AU8135098A (en) | 1999-01-19 |
TR199903272T2 (en) | 2000-08-21 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO950774L (en) | Method of inhibiting bone loss and lowering serum cholesterol | |
NO982414L (en) | New combination | |
BR0206381A (en) | Fumaric acid derivatives as nf-kappab inhibitor | |
HUP0101580A2 (en) | Pharmaceutical compositions capable of being gelled | |
HUP0303083A2 (en) | Pharmaceutical compositions containing therapeutic combination of a cetp inhibitor and atorvastatin and their use | |
BRPI0412526A (en) | compound, use of a compound, pharmaceutical composition, pharmaceutical aerosol formulation, and method for treating a human or animal patient with an anti-inflammatory and / or allergic condition | |
HUP0104258A2 (en) | Stable pharmaceutical formulation comprising a hmg-coa reductase inhibitor | |
ES2185307T3 (en) | FARNESIL TRANSFERASA INHIBITORS THAT HAVE A PIPERIDINIC STRUCTURE AND PROCEDURE FOR THEIR PREPARATION. | |
BR9611802A (en) | Pharmaceutical compositions | |
DE59509751D1 (en) | AGING EFFECTS AGAINST SKIN AGING OR ACTIVE SUBSTANCE COMBINATIONS AND PREPARATIONS | |
CA2213989A1 (en) | External preparation for topical administration | |
NO20075660L (en) | Composition for the treatment of inflammatory diseases | |
BRPI0411255A (en) | compound, pharmaceutical composition, use of a compound, methods of treating a disorder of a patient, and process for the preparation of a compound | |
PT99597B (en) | METHOD FOR THE PREPARATION OF HYDROXAMIC ACID DERIVATIVES THAT INHIBITS LIPOXYGENASE | |
HUP0004396A2 (en) | Pharmaceutical compositions containing hydroxylated cholesterol lowering agent as inhibitor of lipoprotein oxidation | |
BR0211673A (en) | Dermal therapy using phosphate derivatives of electron transfer agents | |
NO996438L (en) | New combination of anti-asthma drugs | |
PA8559401A1 (en) | SUCCINIC ACID SALTS OF 5,7,14-TRIAZATETRACICLO (10.3.1.0 2,11.0 4, 9) -HEXADECA-2 (11), 3,5,7,9-PENTAENO AND PHARMACEUTICAL COMPOSITIONS OF THE SAME. | |
BR0314797A (en) | Pyrimidineamide derivatives and their use | |
ES2045182T3 (en) | PHYSIOLOGICALLY ACTIVE SUBSTANCES, A PROCESS FOR THE PREPARATION OF THE SAME AND PHARMACEUTICAL COMPOSITIONS THAT CONTAIN THEM. | |
DE59608698D1 (en) | Pharmaceutical preparation for the treatment of acute rhinitis, containing sympthomimeticum and pantothenol and / or pantothenic acid | |
BR0317567A (en) | Controlled release pharmaceutical composition of tamsulosin and process for its preparation | |
NO20055601L (en) | Pharmaceutical preparation in the form of a hydrogel for transdermal administration of active ingredients | |
BG98827A (en) | Pharmaceutical composition and method for its preparation | |
BR0110184A (en) | Pyridine-1-oxide derivative, and process for its transformation into pharmaceutically effective compounds |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |